Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents
Medical experts point to a growing body of research linking energy drinks to liver injury
The launch coincides with IBS Awareness Month in April
Subscribe To Our Newsletter & Stay Updated
